The long term objectives of this project are to acquire a molecular level
understanding of the mechanisms that govern cellular control of metabolic
pathways. In particular, to study the actual protein molecules involved
in the regulatory process, to examine the molecular basis by which an
enzyme can regulate its own activity, and to determine how the cell can
regulate the biosynthesis of that particular enzyme. Of all the metabolic
pathways, the biosynthesis of the purines and pyrimidines, which are
required in equal amounts for DNA synthesis, are perhaps the most important
Although these pathways have been studied on a macroscopic level, advances
in crystallography and biotechnology now make it possible to probe the
structure and function of the proteins involved in the control of these
pathways at the microscopic level. The understanding of cellular
regulation and the proteins involved in the control process will have a
great impact on our grasp of cellular differentiation and, as a consequence
of this, cures for cancer and birth defects may be found.
For the next project period, emphasis will be directed towards two aspects
of control of the pyrimidine pathway; first, the enzyme aspartate
transcarbamoylase which regulates this pathway by a combination of genetic,
metabolic and allosteric control mechanisms; and second, the pyrS gene, the
gene-product of which exerts control directly by activating the expression
of two of the enzymes of the pathway. The X-ray structures of aspartate
transcarbamoylase in the two allosteric forms provides for the first time
the necessary structural information to probe this complex system by single
amino acid replacements. By the analysis of mutant forms of this enzyme,
it will be possible to determine on a functional basis how this enzyme can
exert metabolic and allosteric control over pyrimidine biosynthesis. The
understanding of this system on the molecular level is particularly
important because this system has become a model for the understanding of
a diverse number of biological phenomena.
The specific aims for this project period are: (1) use the X-ray structures
of aspartate transcarbamoylase and functional studies employing site-
specific mutants and hybrids to develop and test an integrated model for
homotropic cooperativity (allosteric control) and the heterotropic
interactions (metabolic control) in this enzyme, (2) determine the
molecular level details of the catalytic mechanism of aspartate
transcarbamoylase, (3) determine if second sphere interactions are
important for catalysis and cooperativity in proteins in general and in
aspartate transcarbamoylase in particular, and (4) purify the pyrS
gene-product and determine its interaction with the promoters of the
pyrimidine pathway.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA replicationX ray crystallographyactive sitesallosteric siteaspartate carbamoyltransferasechemical kineticschemical stabilitychemical substitutioncircular dichroismconformationenzyme activityenzyme induction /repressionenzyme mechanismenzyme reconstitutionenzyme structuregel electrophoresishybrid enzymeintermolecular interactionion exchange chromatographylow angle X ray diffraction analysismutantnuclear magnetic resonance spectroscopypolymerase chain reactionprotein engineeringprotein sequencepurine /pyrimidine metabolismregulatory genesite directed mutagenesis
No Sub Projects information available for 5R01GM026237-16
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM026237-16
Patents
No Patents information available for 5R01GM026237-16
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM026237-16
Clinical Studies
No Clinical Studies information available for 5R01GM026237-16
News and More
Related News Releases
No news release information available for 5R01GM026237-16
History
No Historical information available for 5R01GM026237-16
Similar Projects
No Similar Projects information available for 5R01GM026237-16